Re: Farmas USA
Ahi va que cachondeo es esto!!!
Request for Continued Stay in Court Proceedings Submitted in Amarin First Amendment Litigation
Settlement Discussions Continue While Prior Court Ruling Remains in Effect
BEDMINSTER, NJ and DUBLIN, IRELAND -- (Marketwired) -- 02/17/16 -- Amarin Corporation plc (NASDAQ: AMRN), announced today that parties to the Amarin First Amendment litigation have jointly requested a continued stay in court proceedings. Following the August 7, 2015 preliminary relief order granted in favor of Amarin and the physician plaintiffs, the Court was notified that the parties had conferred and agreed to explore the possibility of settlement. As settlement discussions remain ongoing, the parties have requested that further court proceedings be stayed until March 18, 2016. At or before that time, the parties will again file a letter advising the Court of any updates with regard to next steps.
The August 7th declaratory judgment that confirmed Amarin may engage in truthful and non-misleading speech promoting the off-label use of Vascepa remains in effect.